A TRIAL OF GEFITINIB IN COMBINATION WITH BKM120 IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER, WITH ENRICHMENT FOR PATIENTS WHOSE TUMOURS HARBOUR MOLECULAR ALTERATIONS OF PI3K PATHWAY AND KNOWN TO OVEREXPRESS EGFR: